• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 3 filed by new insider Lapping Paul

    8/11/25 4:21:06 PM ET
    $CCCX
    Blank Checks
    Finance
    Get the next $CCCX alert in real time by email
    SEC FORM 3 SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    Lapping Paul

    (Last) (First) (Middle)
    640 FIFTH AVENUE, 14TH FLOOR

    (Street)
    NEW YORK NY 10019

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    08/01/2025
    3. Issuer Name and Ticker or Trading Symbol
    Churchill Capital Corp X/Cayman [ CCCX ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    No securities are beneficially owned.
    /s/ Paul Lapping 08/11/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $CCCX alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CCCX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CCCX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Murphy Stephen Anthony

    3 - Churchill Capital Corp X/Cayman (0002007825) (Issuer)

    8/11/25 4:43:36 PM ET
    $CCCX
    Blank Checks
    Finance

    SEC Form 3 filed by new insider Lapping Paul

    3 - Churchill Capital Corp X/Cayman (0002007825) (Issuer)

    8/11/25 4:21:06 PM ET
    $CCCX
    Blank Checks
    Finance

    $CCCX
    SEC Filings

    View All

    SEC Form 425 filed by Churchill Capital Corp X

    425 - Churchill Capital Corp X/Cayman (0002007825) (Subject)

    11/19/25 4:15:31 PM ET
    $CCCX
    Blank Checks
    Finance

    SEC Form 425 filed by Churchill Capital Corp X

    425 - Churchill Capital Corp X/Cayman (0002007825) (Subject)

    11/14/25 4:45:37 PM ET
    $CCCX
    Blank Checks
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by Churchill Capital Corp X

    SCHEDULE 13G/A - Churchill Capital Corp X/Cayman (0002007825) (Subject)

    11/14/25 4:13:54 PM ET
    $CCCX
    Blank Checks
    Finance

    $CCCX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Infleqtion Chief Scientist Dr. Mark Saffman Wins Prestigious 2026 Norman F. Ramsey Prize

    Award from American Physical Society honors Dr. Saffman's pioneering work in neutral-atom quantum technologies Infleqtion, a global leader in neutral atom–based quantum technology, proudly announces that Dr. Mark Saffman, Chief Scientist for Quantum Information at Infleqtion, has been awarded the prestigious Norman F. Ramsey Prize by the American Physical Society (APS). This recognition underscores the global scientific validation of the neutral-atom approach that powers Infleqtion's product roadmap, bridging world-class academic research with engineered quantum systems designed for scale, reliability, and real-world impact. Infleqtion recently announced plans to go public through a merge

    11/20/25 9:00:00 AM ET
    $CCCX
    Blank Checks
    Finance

    Infleqtion Appoints Jason Hall as Chief Legal Officer

    Hall's appointment strengthens Infleqtion's leadership team as the company advances toward its planned public listing and prepares for its next phase of strategic growth. Global legal executive with more than 15 years of leadership across technology, semiconductor, and energy sectors Former chief legal officer of Renesas Electronics Corporation, a multibillion-dollar publicly traded semiconductor company Led legal strategy on more than $15 billion in acquisitions, more than $6 billion in financings and company-wide strategic initiatives across five continents Infleqtion (the "Company"), a global leader in neutral atom-based quantum technology, has appointed Jason Hall as chief l

    11/19/25 4:15:00 PM ET
    $CCCX
    Blank Checks
    Finance

    Infleqtion and Oak Ridge National Laboratory Partner to Advance Quantum–HPC Integration

    $125M DOE Quantum Science Center renewal accelerates hybrid quantum/classical computing research Infleqtion, a global leader in neutral atom based quantum technology, is collaborating with Oak Ridge National Laboratory (ORNL) through the Department of Energy's Quantum Science Center (QSC) to explore how quantum computers can integrate with the world's most powerful high-performance computing (HPC) systems. The joint research aims to demonstrate real-world utility from hybrid computing systems and establish scalable pathways for future fault-tolerant, quantum accelerated supercomputers. This announcement follows Infleqtion's plans to go public through a merger with Churchill Capital Corp X

    11/18/25 9:00:00 AM ET
    $CCCX
    Blank Checks
    Finance